Enablex and Weight control - a phase IV clinical study of FDA data

Summary:

Weight control is reported as a side effect among people who take Enablex (darifenacin hydrobromide), especially for people who are male, 50-59 old, also take Ambien, and have Bipolar i disorder.

The phase IV clinical study analyzes which people have Weight control when taking Enablex. It is created by eHealthMe based on reports of 4,746 people who have side effects when taking Enablex from the FDA, and is updated regularly.

What is Enablex?

Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.

What is Weight control?

Weight control is found to be associated with 1,940 drugs and 2,333 conditions by eHealthMe. Check the latest studies of Weight control.

On May, 09, 2026

4,746 people reported to have side effects when taking Enablex.
Among them, 10 people (0.21%) have Weight control.

Among these 10 people:

What is the gender of people who have Weight control when taking Enablex? *

female: 30 %
male: 70 %

What is the age of people who have Weight control when taking Enablex? *

What are other drugs people take besides Enablex? *

What are other side effects people have besides Weight control? *

Insomnia (sleeplessness): 8 people, 80.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 8 people, 80.00%
Viral Upper Respiratory Tract Infection: 7 people, 70.00%
Overdose: 7 people, 70.00%
Urinary Tract Infection: 7 people, 70.00%
Chest Pain: 7 people, 70.00%
Cellulitis (infection under the skin): 7 people, 70.00%
Cardiac Failure Congestive: 7 people, 70.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 70.00%
Liver Disorder (liver diseases): 7 people, 70.00%

What are the existing conditions these people have? *

Insomnia (sleeplessness): 7 people, 70.00%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 7 people, 70.00%
Sleep Disorder: 6 people, 60.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 60.00%
Bipolar Disorder (mood disorder): 6 people, 60.00%
Stress And Anxiety: 3 people, 30.00%
Social Phobia (fear to go in social): 3 people, 30.00%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 30.00%
Diabetes: 3 people, 30.00%
Type 2 Diabetes: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Enablex and have Weight control?

- Check whether Weight control is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enablex:

Enablex (4,934 reports)

Weight control treatments and more:

Weight control (62,426 reports)

Browse all side effects of Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight control:

Weight control (1,940 drugs)

Browse all the conditions that are associated with Weight control:

Weight control (2,333 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darifenacin hydrobromide (the active ingredients of Enablex) and Enablex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.